Emerging evidence highlights that aberrant activation of the STAT3 signaling plays a critical role in both cardiac hypertrophy and cancer progression, acting as a shared driver of the pathological processes in HF and tumorigenesis [34]. Here, STAT3 is linked to cardiac hypertrophy.